1.A novel mechanism of bitter taste transduction.
Akimichi KANEKO ; Hiroko TAKEUCHI ; Takashi KURAHASHI ; Takashi TSUNENARI
The Korean Journal of Physiology and Pharmacology 1999;3(5):455-459
Bitter taste is an important warning sign for animals that food is poisonous. The transduction mechanism of bitter taste is still a contradictory matter among researchers. The major current hypothesis, based mainly on biochemical data, involves metabotropic cascades, either via cytoplasmic cyclic nucleotide monophosphate (cNMP) or via IP3. The former hypothesis involves cytoplasmic cNMP. It has been shown that a taste receptor cell expresses a specific G protein (McLaughlin et al, 1992) that activates phosphodiesterase leading to the decomposition of cNMP (Price, 1973; Ruiz-Avila et al, 1995). The frog taste receptor cell has a cationic channel, which is kept closed at a high cNMP concentration. Bitter stimuli reduce the cNMP concentration and release the cationic channel from the closed state (Kolesnikov & Margolskee, 1995). The latter hypothesis involves the cytoplasmic inositol 1,4,5-trisphosphate (IP3) as a second messenger. This hypothesis proposes that a bitter substance increases the cytoplasmic IP3 concentration by activating a G protein and phospholipase C. IP3 triggers Ca2+ release from the endoplasmic reticulum, which in turn directly or indirectly induces transmitter release from the taste receptor cells (Akabas et al, 1988; Hwang et al, 1990; Spielman et al, 1994, Spielman et al, 1996). We found recently an entirely different mechanism for the bitter taste transduction. We excised a patch membrane from an isolated taste receptor cell of the fungiform papillae of the bullfrog (Tsunenari et al, 1996, 1999) and recorded in the outside-out configuration. The patch pipette was filled with a solution containing 120 mM CsCl, 2 mM Na2-EGTA and 10 mM Na-HEPES. The outside of the patch membrane was exposed to the 120 mM NaCl solution containing 120 mM NaCl and 2 mM Na-HEPES. Thus, on the cytoplasmic face of the patch membrane none of the second messenger candidates or their precursors (eg. cyclic nucleotide, IP3, Ca2+, ATP and GTP) was present.
Adenosine Triphosphate
;
Animals
;
Cytoplasm
;
Endoplasmic Reticulum
;
GTP-Binding Proteins
;
Inositol 1,4,5-Trisphosphate
;
Membranes
;
Rana catesbeiana
;
Second Messenger Systems
;
Type C Phospholipases
2.Genomic Profiling Shows Increased Glucose Metabolism in Luminal B Breast Cancer.
Shigeto UEDA ; Toshiaki SAEKI ; Hideki TAKEUCHI ; Takashi SHIGEKAWA ; Kazuo MATSUURA ; Noriko NAKAMIYA ; Hiroshi SANO ; Hiroko SHIMADA ; Eiko HIROKAWA ; Akihiko OSAKI
Journal of Breast Cancer 2013;16(3):342-344
We had previously reported a close association between pathological response and the maximum tumor standardized uptake value (SUVmax) measured by 18F-fluorodeoxyglucose positron emission tomography prior to chemotherapy in estrogen receptor (ER)-positive breast cancer. We hypothesized that glucose hypermetabolism by luminal B tumors may result in chemotherapy responsiveness. Using a single-gene expression assay, TargetPrint(R) (Agendia) and a 70-gene expression classifier, MammaPrint(R) (Agendia), we divided 20 patients with ER-positive primary breast cancer into luminal A and luminal B subtypes and compared the tumor SUVmax value between the two groups. A significantly higher SUVmax was measured for luminal B tumors (n=10; mean+/-SD, 7.6+/-5.6) than for luminal A tumors (n=10; mean+/-SD, 2.6+/-1.2; p=0.01). Glucose hypermetabolism could help predict intrinsic subtyping and chemotherapy responsiveness as a supplement to ER, progesterone receptor, HER2, and Ki-67 histochemical scores.
Breast
;
Breast Neoplasms
;
Estrogens
;
Glucose
;
Humans
;
Phenobarbital
;
Positron-Emission Tomography
;
Receptors, Progesterone
3.Clinical utility of CA-125 in the management of uterine carcinosarcoma.
Koji MATSUO ; Malcolm S ROSS ; Mayu YUNOKAWA ; Marian S JOHNSON ; Hiroko MACHIDA ; Kohei OMATSU ; Merieme M KLOBOCISTA ; Dwight D IM ; Shinya SATOH ; Tsukasa BABA ; Yuji IKEDA ; Stephen H BUSH ; Kosei HASEGAWA ; Erin A BLAKE ; Munetaka TAKEKUMA ; Masako SHIDA ; Masato NISHIMURA ; Sosuke ADACHI ; Tanja PEJOVIC ; Satoshi TAKEUCHI ; Takuhei YOKOYAMA ; Yutaka UEDA ; Keita IWASAKI ; Takahito M MIYAKE ; Shiori YANAI ; Tadayoshi NAGANO ; Tadao TAKANO ; Mian MK SHAHZAD ; Frederick R UELAND ; Joseph L KELLEY ; Lynda D ROMAN
Journal of Gynecologic Oncology 2018;29(6):e88-
No abstract available.
Carcinosarcoma*